KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Pension (2018 - 2019)

Bristol Myers Squibb (BMY) has disclosed Pension for 9 consecutive years, with $2.6 billion as the latest value for Q4 2019.

  • On a quarterly basis, Pension fell 56.42% to $2.6 billion in Q4 2019 year-over-year; TTM through Dec 2019 was $2.6 billion, a 56.42% decrease, with the full-year FY2019 number at $2.6 billion, down 56.42% from a year prior.
  • Pension was $2.6 billion for Q4 2019 at Bristol Myers Squibb, down from $6.0 billion in the prior quarter.
  • In the past five years, Pension ranged from a high of $6.0 billion in Q4 2018 to a low of $727.0 million in Q2 2015.
  • A 3-year average of $2.1 billion and a median of $1.1 billion in 2015 define the central range for Pension.
  • Peak YoY movement for Pension: increased 11.91% in 2015, then crashed 56.42% in 2019.
  • Bristol Myers Squibb's Pension stood at $949.0 million in 2015, then surged by 528.66% to $6.0 billion in 2018, then plummeted by 56.42% to $2.6 billion in 2019.
  • Per Business Quant, the three most recent readings for BMY's Pension are $2.6 billion (Q4 2019), $6.0 billion (Q4 2018), and $949.0 million (Q4 2015).